Translate page



Perspectives from PD Dr. Susanne Saußele
Universitätsklinikum Mannheim, Germany

  • Key criteria for treatment discontinuation
  • The impact comorbidity has on TKI decision making
  • Additional chromosomal aberrations - considerations in clinical practice
  • Highlights of EHA



Comments closed!